OptoVibronex develops the patented OptoScope 2.0, a non-invasive medical imaging and material-characterization device that combines optical coherence tomography with vibrational analysis to map tissue structure and mechanical properties. Based in Mount Bethel, the company is focused particularly on dermatology and aesthetic dermatology, with potential uses in virtual biopsy, wound healing and implant assessment. Co-founder and Chief Technical Officer Dr. Fred Silver brings 35 years as a Rutgers pathology professor, more than 30 patents and over 200 publications on biological materials and their mechanics.
US Patent Number: 10,488,277
EU Patent Pending: Europe # 16866811.9
Registration